Long-Term Data Shows Sustained Skin Clearance in Psoriasis with FDA-Approved Biologic
Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.
Study results presented at EADV 2025 show nearly half of initial complete responders maintained clearance over four years.
A principal investigator discusses new randomized, controlled data on VYC-12L, a hyaluronic acid injectable, studied for reducing transverse neck lines and improving overall neck appearance, with implications for non-surgical neck rejuvenation in aesthetic practice.